Analyst
BTIG
Equibles does not estimate personal net worth.
Luke is recorded as Analyst at BTIG. Luke has spoken on 1 earnings call across 1 company, most recently for Crinetics Pharmaceuticals, Inc. on February 26, 2026. The companies whose calls Luke spoke on are classified in the Healthcare sector.
“So, on the ADCS study, there's a mention that the Phase III endpoints may change based on Phase II data. I suppose is that something that's agreed on in advance with SEA, and can you help us understand what would trigger this change?”
BTIG
Analyst
Transcript header (unverified)
Crinetics Pharmaceuticals, Inc.
Biotechnology · Healthcare
Crinetics Pharmaceuticals, Inc. Q4 FY2025 Earnings Call
Crinetics Pharmaceuticals, Inc.
